Literature DB >> 31104551

A Rare Opportunity: Examining the Experience of a New Institutional Review Board.

Linda Parreco1, Lisa Rooney2, Sharon Hampp1, Amanda Brown1, Lori Minasian1.   

Abstract

The process of creating a new Institutional Review Board (IRB) or Research Ethics Committee (REC) presents many challenges; however, little has been published to describe this experience. Thus, many questions about creating a new IRB/REC and the challenges they face remain. The establishment of a new federal-wide single IRB provided a rare opportunity to describe these experience and outcomes. A census of the activity and outcomes of this new board is reported for its first 3 years of operation: The convened board approved 50 protocols, required an average of 93.24 days and 2.76 reviews for protocol approval, and issued an average of 31.82 stipulations per protocol. The census data helped to identify several issues that impacted the board's outcomes and it serves as a baseline for future comparisons. The overall dynamics, challenges, and outcomes of this new single IRB are discussed.

Entities:  

Keywords:  IRB decision making; IRB membership; IRB metrics; clinical trials; education; performance; quality

Mesh:

Year:  2019        PMID: 31104551      PMCID: PMC6565466          DOI: 10.1177/1556264619841815

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  24 in total

1.  A central institutional review board for multi-institutional trials.

Authors:  Michaele C Christian; Jacquelyn L Goldberg; Jack Killen; Jeffrey S Abrams; Mary S McCabe; Joan K Mauer; Robert E Wittes
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

2.  Using the IRB Researcher Assessment Tool to Guide Quality Improvement.

Authors:  Daniel E Hall; Barbara H Hanusa; Bruce S Ling; Roslyn A Stone; Galen E Switzer; Michael J Fine; Robert M Arnold
Journal:  J Empir Res Hum Res Ethics       Date:  2015-11-02       Impact factor: 1.742

3.  Barriers to clinical trials vary according to the type of trial and the institution.

Authors:  Rangaswamy Govindarajan; James W Young; Cherie L Harless; Laura F Hutchins
Journal:  J Clin Oncol       Date:  2007-04-20       Impact factor: 44.544

4.  Anonymous self-evaluation of performance by ethics board members: a pilot study.

Authors:  James A Feldman; Casey M Rebholz
Journal:  J Empir Res Hum Res Ethics       Date:  2009-03       Impact factor: 1.742

5.  Establishment of a standing ethics/institutional review board in a nigerian university: a blueprint for developing countries.

Authors:  Adeyinka G Falusi; Olufunmilayo I Olopade; Christopher O Olopade
Journal:  J Empir Res Hum Res Ethics       Date:  2007-03       Impact factor: 1.742

6.  Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group.

Authors:  David M Dilts; Alan Sandler; Steven Cheng; Joshua Crites; Lori Ferranti; Amy Wu; Robert Gray; Jean MacDonald; Donna Marinucci; Robert Comis
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

7.  Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.

Authors:  David M Dilts; Alan B Sandler
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

Review 8.  Meeting the Challenge: The National Cancer Institute's Central Institutional Review Board for Multi-Site Research.

Authors:  Holly A Massett; Sharon L Hampp; Jacquelyn L Goldberg; Margaret Mooney; Linda K Parreco; Lori Minasian; Mike Montello; Grace E Mishkin; Catasha Davis; Jeffrey S Abrams
Journal:  J Clin Oncol       Date:  2018-01-31       Impact factor: 44.544

9.  The Impact of Institutional Review Boards (IRBs) on Clinical Innovation: A Survey of Investigators and IRB Members.

Authors:  Tomasz P Stryjewski; Brian T Kalish; Benjamin Silverman; Lisa Soleymani Lehmann
Journal:  J Empir Res Hum Res Ethics       Date:  2015-12       Impact factor: 1.742

10.  Is your ethics committee efficient? Using "IRB Metrics" as a self-assessment tool for continuous improvement at the Faculty of Tropical Medicine, Mahidol University, Thailand.

Authors:  Pornpimon Adams; Jaranit Kaewkungwal; Chanthima Limphattharacharoen; Sukanya Prakobtham; Krisana Pengsaa; Srisin Khusmith
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.